Immunic Insider Trades
NASDAQ: IMUXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Immunic insider activity
No Immunic insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Nash Duane (Executive Chairman) buying 20,000 shares at $0.8347 on Jun 13, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IMUX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IMUX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 13, 2025 | Nash DuaneExecutive Chairman | Buy | 20,000 | $16.69K | Form 4 |
| Jun 5, 2025 | Tardio JasonPresident and COO | Buy | 12,512 | $9.88K | Form 4 |
| Jun 5, 2025 | Tardio JasonPresident and COO | Buy | 12,512 | $9.88K | Form 4 |
| Jun 4, 2025 | Vitt DanielCEO and Director | Buy | 15,000 | $11.55K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4